---
$id: https://graph.org.ai/products/commodity/51111751
$type: Product
source: UNSPSC
code: "51111751"
title: "Ortetamine"
class: "51111700"
classTitle: "Antineoplastic antibiotics"
family: "51110000"
familyTitle: "Antineoplastic agents"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Ortetamine

**UNSPSC Code**: 51111751
**Class**: [Antineoplastic antibiotics](Antineoplastic antibiotics.mdx)
**Family**: [Antineoplastic agents](../Antineoplastic agents.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an anorexiant with the molecular formula C10H15N, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier VF4N11KKKR, chemically known as 1,1-dimethyl-2-phenylethylamine but generally known as ortetamine, which bears US NIH Compound Identifier 4771. European Medicines Agency schedules Ortetamine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09472MIG. The term ORTETAMINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 19 1975, List 5). ORTETAMINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule ortetamine under HS 29214980 and SITC 51454. As of Q4 2014, ORTETAMINE remains the US FDA Preferred Term for this commodity. Ortetamine bears US NLM identifiers UMLS ID C2698659 and NCI Concept Code C75115. SMILES: CC(C)(CC1=CC=CC=C1)N.

